You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MBRX Exercise Disclosure
Foster Jonathan P. · SEC Form 4 · Filed Oct 16, 2026
Exercise
Calculated transaction value
$0
Foster Jonathan P. Chief Financial Officer
MBRX
Transaction date
Oct 15, 2026
Public filing date
Oct 16, 2026
Filing lag
Filed 1 day later
MBRX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 130,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001437749-26-032864
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$11.28K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moleculin Biotech, Inc. MBRX | Award | Oct 15, 2026 | Not reported |
| Moleculin Biotech, Inc. MBRX Current | Exercise | Oct 15, 2026 | $0 |
| Moleculin Biotech, Inc. MBRX | Disposition | Oct 15, 2026 | $11.28K |
| Moleculin Biotech, Inc. MBRX | Award | Oct 15, 2026 | Not reported |
| Moleculin Biotech, Inc. MBRX | Exercise | Oct 15, 2026 | Not reported |